| Title: |
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation. |
| Authors: |
Proietti M, Marra AM; Tassone, Ej; De Vuono, S; Corrao, S; Gobbi, P; Perticone, F; Corazza, Gr; Basili, S; Lip, Gy; Violi, F; Raparelli, V; Investigators, ARAPACIS Study; Group, Gis; MANFREDINI, Roberto; FABBIAN, Fabio |
| Contributors: |
Proietti M, Marra AM; Tassone, Ej; De Vuono, S; Corrao, S; Gobbi, P; Perticone, F; Corazza, Gr; Basili, S; Lip, Gy; Violi, F; Raparelli, V; Investigators, ARAPACIS Study; Group, Gi; Manfredini, Roberto; Fabbian, Fabio |
| Publication Year: |
2015 |
| Collection: |
Università degli Studi di Ferrara: CINECA IRIS |
| Subject Terms: |
non-valvular atrial fibrillation; left ventricular hypertrophy; echocardiography; cardiovascular diseases |
| Description: |
Left ventricular hypertrophy (LVH) is significantly related to adverse clinical outcomes in patients at high risk of cardiovascular events. In patients with atrial fibrillation (AF), data on LVH, that is, prevalence and determinants, are inconsistent mainly because of different definitions and heterogeneity of study populations. We determined echocardiographic-based LVH prevalence and clinical factors independently associated with its development in a prospective cohort of patients with non-valvular (NV) AF. From the "Atrial Fibrillation Registry for Ankle-brachial Index Prevalence Assessment: Collaborative Italian Study" (ARAPACIS) population, 1,184 patients with NVAF (mean age 72 ± 11 years; 56% men) with complete data to define LVH were selected. ARAPACIS is a multicenter, observational, prospective, longitudinal on-going study designed to estimate prevalence of peripheral artery disease in patients with NVAF. We found a high prevalence of LVH (52%) in patients with NVAF. Compared to those without LVH, patients with AF with LVH were older and had a higher prevalence of hypertension, diabetes, and previous myocardial infarction (MI). A higher prevalence of ankle-brachial index ≤0.90 was seen in patients with LVH (22 vs 17%, p = 0.0392). Patients with LVH were at significantly higher thromboembolic risk, with CHA2DS2-VASc ≥2 seen in 93% of LVH and in 73% of patients without LVH (p |
| Document Type: |
article in journal/newspaper |
| File Description: |
STAMPA |
| Language: |
English |
| Relation: |
info:eu-repo/semantics/altIdentifier/wos/WOS:000361643800008; volume:116; issue:6; firstpage:877; lastpage:882; numberofpages:6; journal:THE AMERICAN JOURNAL OF CARDIOLOGY; https://hdl.handle.net/11392/2329650 |
| DOI: |
10.1016/j.amjcard.2015.05.060 |
| Availability: |
https://hdl.handle.net/11392/2329650; https://doi.org/10.1016/j.amjcard.2015.05.060 |
| Accession Number: |
edsbas.45ABF39C |
| Database: |
BASE |